Literature DB >> 18287252

Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.

Samih H Nasr1, Vivette D D'Agati, Hye-Ran Park, Paul L Sterman, Juan D Goyzueta, Robert M Dressler, Shawn M Hazlett, Robert N Pursell, Christopher Caputo, Glen S Markowitz.   

Abstract

BACKGROUND AND OBJECTIVES: Lupus nephritis is a classic immune complex glomerulonephritis. In contrast, antineutrophil cytoplasmic antibodies are associated with necrotizing and crescentic glomerulonephritis, in the absence of significant immune deposits. Antineutrophil cytoplasmic antibodies are detected by indirect immunofluorescence in 20% of patients with systemic lupus erythematosus. We report 10 cases of necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Ten patients with systemic lupus erythematosus, antineutrophil cytoplasmic antibody positivity, and renal biopsy findings of lupus nephritis and antineutrophil cytoplasmic antibody-associated glomerulonephritis were identified. The clinical features, pathologic findings, and outcomes are described.
RESULTS: The cohort consisted of eight women and two men with a mean age of 48.4 yr. Perinuclear antineutrophil cytoplasmic antibody was detected by indirect immunofluorescence in nine patients. Four of the nine patients and the single remaining patient were found to have myeloperoxidase-antineutrophil cytoplasmic antibodies by enzyme-linked immunosorbent assay. Clinical presentation included proteinuria, hematuria, and acute renal insufficiency, with mean creatinine of 7.1 mg/dl. All biopsies exhibited prominent necrosis and crescents with absent or rare subendothelial deposits and were interpreted as lupus nephritis and antineutrophil cytoplasmic antibody-associated glomerulonephritis. All patients received cyclophosphamide and prednisone. Three patients died of infectious complications. Among the remaining seven patients, five achieved a complete or near-complete remission, one had a remission with subsequent relapse, and one had no response to therapy.
CONCLUSION: Antineutrophil cytoplasmic antibody-associated necrotizing and crescentic glomerulonephritis may occur superimposed on lupus nephritis. In patients with lupus nephritis and biopsy findings of prominent necrosis and crescent formation in the absence of significant endocapillary proliferation or subendothelial deposits, antineutrophil cytoplasmic antibody testing by enzyme-linked immunosorbent assay is recommended.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287252      PMCID: PMC2386714          DOI: 10.2215/CJN.04391007

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  25 in total

1.  Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.

Authors:  H K Choi; P A Merkel; A M Walker; J L Niles
Journal:  Arthritis Rheum       Date:  2000-02

2.  ANCA-positive vasculitis induced by thioridazine: confirmed by rechallenge.

Authors:  J R Greenfield; M McGrath; S Kossard; J A Charlesworth; L V Campbell
Journal:  Br J Dermatol       Date:  2002-12       Impact factor: 9.302

Review 3.  Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus.

Authors:  D Sen; David A Isenberg
Journal:  Lupus       Date:  2003       Impact factor: 2.911

4.  "Pauci-Immune" proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythematosus and lupus-like syndrome.

Authors:  D A Charney; G Nassar; L Truong; T Nadasdy
Journal:  Am J Kidney Dis       Date:  2000-06       Impact factor: 8.860

5.  Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis.

Authors:  C C Najafi; S M Korbet; E J Lewis; M M Schwartz; M Reichlin; J Evans
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Antilactoferrin antibody in systemic lupus erythematosus.

Authors:  S S Lee; J W Lawton; C E Chan; C S Li; T H Kwan; K F Chau
Journal:  Br J Rheumatol       Date:  1992-10

8.  Hydralazine and lupus nephritis.

Authors:  B U Ihle; J A Whitworth; J P Dowling; P Kincaid-Smith
Journal:  Clin Nephrol       Date:  1984-11       Impact factor: 0.975

Review 9.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

10.  Necrotizing glomerulitis of systemic lupus erythematosus.

Authors:  M M Schwartz; J L Roberts; E J Lewis
Journal:  Hum Pathol       Date:  1983-02       Impact factor: 3.466

View more
  40 in total

Review 1.  Histopathology of lupus nephritis.

Authors:  Konstantinos Giannakakis; Tullio Faraggiana
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

2.  ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis.

Authors:  Jung Yoon Pyo; Seung Min Jung; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2019-02-26       Impact factor: 2.631

3.  TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.

Authors:  Lukas Bossaller; Anette Christ; Karin Pelka; Kerstin Nündel; Ping-I Chiang; Catherine Pang; Neha Mishra; Patricia Busto; Ramon G Bonegio; Reinhold Ernst Schmidt; Eicke Latz; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2016-06-27       Impact factor: 5.422

4.  Renal cocktail: too hard for a diabetic.

Authors:  Ankur Gupta; Mohan Biyani; Susan J Robertson
Journal:  Int Urol Nephrol       Date:  2011-07-22       Impact factor: 2.370

5.  An Elderly Man with Fatigue, Dyspnea, and Kidney Failure.

Authors:  Andrew S Bomback
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-08       Impact factor: 8.237

6.  AP-VAS 2012 case report: a case of lupus nephritis with predominant synchronous cellular crescent formation and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity.

Authors:  Tetsuya Makiishi; Tomoyuki Shirase; Shinya Yamamoto; Sayako Maeda
Journal:  CEN Case Rep       Date:  2013-01-30

7.  Combined membranous nephropathy and crescentic glomerulonephritis with concurrent anti-glomerular basement membrane antibody and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody.

Authors:  Yoichi Iwafuchi; Takashi Morita; Yuko Oyama; Akira Kamimura; Shigeru Miyazaki; Ichiei Narita
Journal:  CEN Case Rep       Date:  2013-01-30

Review 8.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

Review 9.  Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?

Authors:  B Hervier; M Hamidou; J Haroche; C Durant; A Mathian; Z Amoura
Journal:  Rheumatol Int       Date:  2011-07-30       Impact factor: 2.631

10.  Diffuse alveolar hemorrhage in lupus nephritis complicated by microscopic polyangiitis.

Authors:  Motohide Isono; Hisazumi Araki; Takao Haitani; Yoshikata Morita; Mako Yasuda; Noriko Kato; Koji Urasaki; Yoshinori Tsujimura
Journal:  Clin Exp Nephrol       Date:  2011-01-12       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.